Central Venous Catheter Market: By Type, By Procedure & By Geography - Forecast 2016-2021

  • ID: 3973885
  • Report
  • 131 pages
  • IndustryARC
1 of 3
A central venous catheter, also referred as central line. Central venous catheter is inserted into large vein in the neck, or chest to monitor cardiovascular health of the patient or to give medicines, fluids, nutrients, or blood products when the patient under observation is suffering with diseases such as cancer, cardiovascular diseases, and renal failure and traditional way of providing medicines or nutrients is not working.

This report identifies the central venous catheter market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to central venous catheter market.

Globally North America dominated the market for central venous catheter in 2015 followed by Europe as second largest regional market. Major factor behind dominance of these two regions in central venous catheter market place are estimated to be high reported cases of cardiac and cancer related diseases well as well-established healthcare infrastructure equipped with advanced machines and equipment in these regions. Asia- Pacific is expected to witness strong growth in the central venous catheter market during the period of study due to increasing reported instances of the cardiac and cancer disease coupled with increasing awareness and rapidly developing healthcare infrastructure in the region especially in major developing economies like India and China.

This report on global central venous catheter also covers different type central venous catheter, major procedure performed by central venous catheter and market size in various geographical regions.

The report covers major types of central venous catheter, some of the major central venous catheter types are as follows: Peripherally inserted central catheters (PICC), Tunnelled Central Venous Catheter and Non-Tunnelled Central Venous Catheter
This report also identifies major procedures performed by central venous catheter, some of the major procedures covered in this report are as follows: Cardiovascular procedures, Chemotherapy procedures and Dialysis procedures
This report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for central venous catheter in each of the region.

This report identifies all the major companies operating in the global central venous catheter market. Some of the major companies’ profiles in detail are as follows:
Becton Dickinson Company
Edwards Life sciences Corporation
B.Braun Melsungen AG
C. R. Bard Inc
Terumo Corporation
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Central Venous Catheter – Market Overview

2. Executive Summary

3. Central Venous Catheter Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis

4. Central Venous Catheter – Market Forces
4.1. Drivers
4.1.1. Increasing global population with cardiac and cancerous diseases
4.1.2. Developing healthcare infrastructure in emerging nations
4.2. Restraints
4.3. Opportunities
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Central Venous Catheter Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Global Central Venous Catheter Market, By Type
6.1. Peripherally inserted central catheters (PICC)
6.2. Tunnelled Central Venous Catheter
6.3. Non-Tunnelled Central Venous Catheter

7. Global Central Venous Catheter Market By Procedure
7.1. Cardiovascular procedures
7.2. Chemotherapy procedures
7.3. Dialysis procedures

8. Global Central Venous Catheter Market By Geography
8.1. Europe
8.1.1. Germany
8.1.2. France
8.1.3. Italy
8.1.4. Spain
8.1.5. Russia
8.1.6. U.K.
8.1.7. Rest of Europe
8.2. Asia Pacific
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.4. South Korea
8.2.5. Rest of Asia-Pacific
8.3. North America
8.3.1. U.S.
8.3.2. Canada
8.3.3. Mexico
8.4. Rest of the World (RoW)
8.4.1. Brazil
8.4.2. Rest of RoW

9. Central Venous Catheter – Market Entropy
9.1. Expansion
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply- Contract

10. Company Profiles
10.1. Becton Dickinson Company
10.1.1. Introduction
10.1.2. Financials
10.1.3. Key Insights
10.1.4. Key Strategy
10.1.5. Product Portfolio
10.1.6. SWOT Analysis
10.2. Edwards Life sciences Corporation
10.2.1. Introduction
10.2.2. Financials
10.2.3. Key Insights
10.2.4. Key Strategy
10.2.5. Product Portfolio
10.2.6. SWOT Analysis
10.3. B.Braun Melsungen AG
10.3.1. Introduction
10.3.2. Financials
10.3.3. Key Insights
10.3.4. Key Strategy
10.3.5. Product Portfolio
10.3.6. SWOT Analysis
10.4. C. R. Bard Inc
10.4.1. Introduction
10.4.2. Financials
10.4.3. Key Insights
10.4.4. Key Strategy
10.4.5. Product Portfolio
10.4.6. SWOT Analysis
10.5. Terumo Corporation
10.5.1. Introduction
10.5.2. Financials
10.5.3. Key Insights
10.5.4. Key Strategy
10.5.5. Product Portfolio
10.5.6. SWOT Analysis
10.6. Smiths Medical
10.6.1. Introduction
10.6.2. Financials
10.6.3. Key Insights
10.6.4. Key Strategy
10.6.5. Product Portfolio
10.6.6. SWOT Analysis
10.7. Teleflex Incorporated
10.7.1. Introduction
10.7.2. Financials
10.7.3. Key Insights
10.7.4. Key Strategy
10.7.5. Product Portfolio
10.7.6. SWOT Analysis
10.8. Johnson and Johnson
10.8.1. Introduction
10.8.2. Financials
10.8.3. Key Insights
10.8.4. Key Strategy
10.8.5. Product Portfolio
10.8.6. SWOT Analysis
10.9. Rochester Medical Co
10.9.1. Introduction
10.9.2. Financials
10.9.3. Key Insights
10.9.4. Key Strategy
10.9.5. Product Portfolio
10.9.6. SWOT Analysis
10.10. Medrad (Bayer AG)
10.10.1. Introduction
10.10.2. Financials
10.10.3. Key Insights
10.10.4. Key Strategy
10.10.5. Product Portfolio
10.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

11. Appendix
11.1. Abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Expert Insights
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown